Ethical Promotion of Medicines: Latest Developments and Future Prospects
Read moreAfrican research foundation partners with international pharmaceutical industry to strengthen capacity for health innovation in Africa
28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced today a three-year partnership to strengthen capacity for health innovation in Africa. The two organizations will combine forces to focus on driving capacity strengthening for drug discovery and development in Africa by scaling existing initiatives and...
Read moreLet’s fast track new approaches to achieve UHC and beat NCDs
Since the start of the 21st century, Gavi, the Vaccine Alliance, has transformed lives, preventing more than 10 million potential deaths. In 2002, when AIDS, TB and malaria appeared unstoppable, the Global Fund to fight these three fatal diseases was created and since then has saved millions of lives – 27 million as of 2017....
Read moreFramework for action for the prevention and control of non-communicable diseases
FPMA believes it is imperative to underscore the importance of NCDs as a key component of sustainable development, by revisiting its Framework to ensure it is relevant and applicable in the post-2015 agenda.
Read more
Jumping the Health Care Hurdles: UHC and Non-Communicable Diseases
This blog was originally posted on Devex. An estimated 400 million people do not have access to basic health care services. That’s about 1 in every 16 people who cannot visit a hospital or clinic to have their blood pressure measured, or learn how to properly care for their child with diabetes. Universal health coverage...
Read moreBolstering action against future pandemics: pharma policy perspectives on delivering medical countermeasures
The annual World Health Summit (WHS) provided a platform for the global health community to take stock of the world’s response to the current COVID-19 pandemic, as well other pressing health threats, such as the rise of antimicrobial resistance, which could next sweep the world. At the WHS, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced its policy perspectives on preparing society against future pandemics.
Read more2016 IFPMA General Assembly-Concluding remarks by Ian Read
Committed to a Healthier Future 2016 IFPMA General Assembly 30 November 2016 Concluding remarks by Ian Read Incoming President, IFPMA, Chairman of the Board and Chief Executive Officer, Pfizer Good afternoon. I am delighted to be with you this afternoon. I want to begin by thanking Stefan Oschmann for his outstanding leadership over the past...
Read moreToo slow for too long: ICDRA will put a spotlight on access to medicine in Africa, and the power of collaboration
Since its inception in 1980, the International Conference of the Drug Regulatory Authorities (ICDRA) represents a major platform for WHO and drug regulatory authorities across its member states, in their efforts to harmonize regulation and improve the safety, efficacy, and quality of medicines. The focus of this year’s ICDRA Conference held in Cape Town at...
Read moreImproving child health around the world through immunisation
Ever since the smallpox vaccine discovery over two centuries ago, vaccines have successfully worked to eradicate, eliminate, or control many infectious diseases.
Read more
WHA 65 agenda item 13.14 on consultative expert working group on research and development
IFPMA Statement, WHA 65, Item 13.14, Consultative expert working group on research and development: financing and coordination Delivered by Mario Ottiglio, Associate Director, Public Affairs & Global Health Policy Thank you on behalf of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), for the opportunity to provide our perspective on this topic. We represent...
Read more